March 24 Is World TB Day
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 24 March 2015 00:00
- Written by HIVandHepatitis.com
March 24 is World TB Day, an opportunity to raise awareness about tuberculosis (TB) and the need for expanded testing and treatment worldwide. The latest data from the CDC indicate that TB cases in the U.S. have reached an all-time low of 9412 cases, but the decline has slowed. Globally, the World Health Organization (WHO) estimates that 9 million people fell ill with TB -- including 480,000 with multidrug-resistant TB -- and 1.5 million people died from the disease in 2013. An estimated 1.1 million people living with HIV were coinfected with TB in 2013, and TB is among the leading causes of death for HIV-positive people, accounting for 25% of all HIV-related deaths.
World TB Day: Find, Treat, and Cure Tuberculosis
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 24 March 2015 00:00
- Written by HIVandHepatitis.com
In recognition of World TB Day on March 24, organizations released their latest figures on tuberculosis in the U.S. and worldwide and called for more action to improve access to testing, care, and treatment, while 2 recent studies offered promise for shorter therapy.
PaMZ Combination Regimen Shortens and Simplifies Tuberculosis Treatment
CROI 2015: High-Dose Rifampin Shortens Time to Tuberculosis Clearance
3/24/15
CROI 2015: High-Dose Rifampin Shortens Time to Tuberculosis Clearance
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 24 March 2015 00:00
- Written by Liz Highleyman
A combination regimen containing high-dose rifampin (also known as rifampicin) was associated with faster tuberculosis bacteria culture conversion in people with drug-sensitive TB, but moxifloxacin and the experimental drug SQ109 showed no benefit compared to standard therapy, according to results from a study presented at the recent 2015 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.
PaMZ Combination Regimen Shortens and Simplifies Tuberculosis Treatment
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 24 March 2015 00:00
- Written by TB Alliance
An oral regimen combining the new drug pretomanid (PA-824) with the older moxifloxacin and pyrazinamide -- known as PaMZ for short -- has the potential to reduce the duration of treatment for drug-sensitive and even some drug-resistant tuberculosis (TB), according to findings from a study published in the March 17 online edition The Lancet. Nearly twice as many patients treated with the PaMZ regimen had undetectable TB in cultured sputum compared to those taking standard therapy.
March 24 Is World TB Day
- Details
- Category: Tuberculosis (TB)
- Published on Monday, 23 March 2015 00:00
- Written by HIVandHepatitis.com
March 24 is World TB Day, an opportunity to raise awareness about tuberculosis (TB) and the need for expanded testing and treatment worldwide. The World Health Organization's theme for 2016 is "Unite to End Tuberculosis". Ending TB by 2030 is a target of the United Nations' Sustainable Development Goals.
More Articles...
- Isoniazid Alone Prevents TB in People with Advanced HIV, Urine Test May Cut Mortality
- CROI 2015: XDR-TB in South Africa is Largely Spread Person-to-Person, Not By Treatment Failure
- CROI 2015: XDR TB Transmission in High-HIV-Prevalence Settings [VIDEO]
- CROI 2015: Early ART and Isoniazid Preventive Therapy Reduce Risk of Illness and Death in Africa
Web Design and Development by